Berkshire Hathaway bets $9.7bn on OxyChem—why Occidental Petroleum is walking away from chemicals

Berkshire Hathaway Inc. (NYSE: BRK) has signed a definitive agreement to acquire Occidental Petroleum Corporation’s (NYSE: OXY) chemical subsidiary, Occidental Chemical Corporation, in a cash deal valued at $9.7 billion. The transaction, announced on October 2, 2025, is expected to close in the fourth quarter subject to regulatory approvals and standard closing conditions. The move represents one of the largest chemicals sector divestments in recent years and signals a sharp strategic pivot for Occidental Petroleum as it doubles down on its core oil and gas business.

Occidental Petroleum confirmed that it will deploy $6.5 billion of the proceeds toward immediate debt reduction, bringing its total debt load to below the $15 billion threshold set after its CrownRock acquisition in late 2023. The remainder of the proceeds, estimated at $1.5 billion post-tax, will strengthen the balance sheet and reinforce capital flexibility. Berkshire Hathaway, meanwhile, is absorbing a business that manufactures essential commodity chemicals used across water treatment, pharmaceuticals, healthcare, and construction, adding another stable industrial cash generator to its diverse portfolio.

Why does Occidental Petroleum see the OxyChem sale as a pivotal shift toward its upstream portfolio?

Occidental Petroleum’s leadership framed the divestment as a way to accelerate resource development in its oil and gas portfolio. Chief executive officer Vicki Hollub emphasized that the deal unlocks a twenty-year runway of low-cost resources by allowing the company to reallocate capital from chemicals to upstream investments. She noted that Occidental Petroleum has been building toward this strategic resource opportunity for more than a decade, and that shedding the chemicals unit will allow the oil and gas producer to focus on organic expansion, enhanced recovery technologies, and efficiency-driven growth.

The company has already achieved more than $2 billion in annualized cost savings across its U.S. onshore operations between 2023 and the first half of 2025. Those savings stemmed from improvements in drilling, completions, and facilities optimization, and were reflected in lower breakeven costs across the Delaware Basin, Midland Basin, Powder River Basin, and Central Basin Platform. The proceeds from OxyChem’s sale are expected to accelerate development of new benches in the Delaware Basin, expand the Barnett play in the Midland Basin, and progress unconventional enhanced oil recovery from demonstration to commercial scale. Occidental also outlined plans to advance waterflood projects in the Gulf of Mexico and broaden international exploration in selected basins.

How does this divestment align with Occidental Petroleum’s debt reduction and shareholder return commitments?

The proceeds will help Occidental Petroleum realize more than $350 million in annual interest expense savings. The company’s investor presentation accompanying the announcement highlighted that immediate debt repayment will materially improve credit metrics and give the business financial flexibility to execute shareholder-friendly capital allocation.

By achieving its sub-$15 billion debt target, Occidental Petroleum clears the path to reinitiate a multi-year share repurchase program, retire preferred equity beginning in 2029, and sustain its dividend program. Hollub has positioned these actions as an “enterprise value rebalancing,” designed to build long-term trust with shareholders who have been wary of Occidental’s high debt load since the $55 billion Anadarko Petroleum acquisition in 2019.

Institutional sentiment indicates cautious optimism. Many investors had questioned whether Occidental could meaningfully reduce leverage while still investing in growth. The OxyChem divestment answers that concern by removing a non-core business, reducing financial strain, and freeing up capital for high-return upstream developments. Analysts have described the transaction as a “strategic rebalancing” that enhances Occidental’s competitive positioning in shale while de-risking its balance sheet.

What does Berkshire Hathaway gain by acquiring Occidental Chemical Corporation?

For Berkshire Hathaway, the acquisition adds a durable, cash-flowing industrial asset that aligns with its philosophy of acquiring essential businesses and letting them operate with continuity. Occidental Chemical Corporation is one of the leading U.S. producers of chlorine, caustic soda, and PVC, products that are foundational to construction, pharmaceuticals, healthcare, and water infrastructure.

Vice chairman Greg Abel praised Occidental’s management for building a well-run business and confirmed that OxyChem will be welcomed as a standalone operating subsidiary within Berkshire. Abel noted that the acquisition underscores Berkshire’s commitment to adding resilient industrial operations backed by accomplished management teams.

The deal fits squarely into Warren Buffett’s long-term approach of acquiring businesses with predictable earnings, strong cash flow, and a critical role in the economy. By purchasing OxyChem, Berkshire gains exposure to the chemicals sector at a time of global infrastructure expansion and rising demand for healthcare and water treatment inputs.

How is the market reacting to the $9.7 billion transaction and what does it signal for Occidental Petroleum’s stock?

Shares of Occidental Petroleum (NYSE: OXY) moved modestly higher in pre-market trading on the day of the announcement, reflecting investor approval of the debt reduction and capital reallocation strategy. The reaction suggested that institutional investors see the sale as credit-positive, with debt repayment expected to lower financial risk and strengthen the company’s investment-grade profile.

Analysts have noted that Occidental’s equity story has long been clouded by the debt overhang from Anadarko. The OxyChem sale demonstrates that the company is willing to make bold moves to restore balance sheet strength and accelerate shareholder returns. Near-term stock sentiment has leaned toward a “hold with upward bias,” as investors await evidence of execution on upstream projects. Foreign institutional investors have shown renewed interest, while domestic institutional investors are likely to view the deleveraging as a reason to maintain positions.

The market is also watching how Occidental manages commodity price volatility. While the company has lowered its breakeven cost base, its fortunes remain tied to oil and gas prices. With global demand still in flux and OPEC supply actions influencing market balance, Occidental’s ability to deliver consistent free cash flow will remain central to its valuation.

What is the long-term outlook for Occidental Petroleum after divesting its chemical unit?

Occidental Petroleum now re-emerges as a more streamlined upstream player. The company intends to focus on unconventional EOR technologies, subsurface characterization, and integrated CO₂ and power systems designed to enhance recovery across its global operations. Hollub has repeatedly emphasized that the freed capital will accelerate growth in core basins, strengthen resource potential, and unlock shareholder value.

The strategy is built on efficiency, with continued progress expected in lowering capital and operating costs. By advancing unconventional EOR from pilot to commercial scale, Occidental hopes to maximize returns from existing acreage. At the same time, exploration in the Gulf of Mexico and select international plays provides additional upside.

For Berkshire Hathaway, the acquisition secures a chemical business that generates steady cash flow regardless of oil price cycles. Analysts have framed the deal as mutually beneficial: Occidental secures financial flexibility and debt relief, while Berkshire adds another resilient asset to its industrial base.

The long-term success of the divestment will depend on Occidental’s execution in oil and gas, the trajectory of commodity prices, and its ability to deliver shareholder returns consistently. If successful, the OxyChem sale may be remembered as a turning point that repositioned Occidental Petroleum for a new phase of growth, while handing Berkshire Hathaway a steady industrial performer.